On May 3, 2021, Moderna announced an agreement with Gavi, the Vaccine Alliance to supply up to 500 million doses of the COVID-19 Vaccine Moderna, including an initial 34 million doses to be delivered in the fourth quarter of 2021.

Through this agreement, on behalf of the COVAX Facility, Gavi also retained the option to procure 466 million additional doses in 2022. All doses are offered at Modernaﾒs lowest tiered price, in line with the Companyﾒs global access commitments.